Acorda Therapeutics Inc (NASDAQ:ACOR)

29.45
Delayed Data
As of Jun 22
 -0.45 / -1.51%
Today’s Change
16.55
Today|||52-Week Range
36.35
+37.30%
Year-to-Date

Today’s Trading

Previous close29.90
Today’s open29.95
Day’s range28.60 - 29.95
Volume808,822
Average volume (3 months)583,002
Market cap$1.2B
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-539.47%
Earnings growth (this year)-129.06%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+13.22%
P/E ratioNM
Price/Sales1.68
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+1.40+3.50%
ZIOPZIOPHARM Oncology In...-0.10-3.04%
ATNXAthenex Inc+0.43+2.31%
BYSIBeyondspring Inc+0.28+1.06%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.68
Annual revenue (last year)$588.3M
Annual profit (last year)-$223.4M
Net profit margin-37.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer Emeritus
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts